share_log

Mustang Bio Analyst Ratings

Mustang Bio Analyst Ratings

野馬生物分析師評級
Benzinga ·  2023/08/15 18:34
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/15/2023 520.35% HC Wainwright & Co. → $25 Reiterates Buy → Buy
06/16/2023 396.28% BTIG $4 → $20 Maintains Buy
06/16/2023 520.35% HC Wainwright & Co. → $25 Reiterates Buy → Buy
05/15/2023 73.7% HC Wainwright & Co. → $7 Reiterates Buy → Buy
03/30/2023 73.7% HC Wainwright & Co. → $7 Reiterates → Buy
11/16/2022 -0.74% BTIG $8 → $4 Maintains Buy
01/24/2022 48.88% B. Riley Securities $13 → $6 Maintains Buy
05/18/2021 172.95% BTIG → $11 Initiates Coverage On → Buy
12/23/2020 222.58% B. Riley FBR → $13 Reinstates → Buy
10/02/2020 123.33% B. Riley Securities → $9 Initiates Coverage On → Buy
05/12/2020 222.58% Oppenheimer $15 → $13 Maintains Outperform
11/20/2019 73.7% Cantor Fitzgerald → $7 Assumes → Overweight
08/13/2019 — HC Wainwright & Co. Initiates Coverage On → Buy
08/13/2019 73.7% HC Wainwright & Co. → $7 Initiates Coverage On → Buy
06/21/2019 73.7% Cantor Fitzgerald → $7 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
08/15/2023 520.35% HC Wainwright & Co. → 25 美元 重申 購買 → 購買
06/16/2023 396.28% BTIG 4 美元 → 20 美元 維護 購買
06/16/2023 520.35% HC Wainwright & Co. → 25 美元 重申 購買 → 購買
05/15/2023 73.7% HC Wainwright & Co. → 7 美元 重申 購買 → 購買
03/30/2023 73.7% HC Wainwright & Co. → 7 美元 重申 → 購買
11/16/2022 -0.74% BTIG 8 美元 → 4 美元 維護 購買
2022 年 1 月 24 日 48.88% B. 萊利證券 13 美元 → 6 美元 維護 購買
05/18/2021 172.95% BTIG → 11 美元 啓動覆蓋開啓 → 購買
2020 年 12 月 23 日 222.58% B. Riley FBR → 13 美元 恢復 → 購買
2020 年 2 月 10 日 123.33% B. 萊利證券 → 9 美元 啓動覆蓋開啓 → 購買
05/12/2020 222.58% 奧本海默 15 美元 → 13 美元 維護 跑贏大盤
2019 年 11 月 20 日 73.7% 坎託·菲茨傑拉德 → 7 美元 假設 → 超重
08/13/2019 — HC Wainwright & Co. 啓動覆蓋開啓 → 購買
08/13/2019 73.7% HC Wainwright & Co. → 7 美元 啓動覆蓋開啓 → 購買
06/21/2019 73.7% 坎託·菲茨傑拉德 → 7 美元 啓動覆蓋開啓 → 超重

What is the target price for Mustang Bio (MBIO)?

野馬生物（MBIO）的目標價格是多少？

The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $25.00 expecting MBIO to rise to within 12 months (a possible 520.35% upside). 6 analyst firms have reported ratings in the last year.

HC Wainwright & Co. 於2023年8月15日公佈了Mustang Bio（納斯達克股票代碼：MBIO）的最新目標股價。這家分析公司將目標股價定爲25.00美元，預計MBIO將在12個月內升至25.00美元（可能上漲520.35％）。去年有6家分析公司公佈了評級。

What is the most recent analyst rating for Mustang Bio (MBIO)?

分析師對野馬生物（MBIO）的最新評級是多少？

The latest analyst rating for Mustang Bio (NASDAQ: MBIO) was provided by HC Wainwright & Co., and Mustang Bio reiterated their buy rating.

Mustang Bio（納斯達克股票代碼：MBIO）的最新分析師評級由HC Wainwright & Co. 提供，Mustang Bio重申了他們的買入評級。

When is the next analyst rating going to be posted or updated for Mustang Bio (MBIO)?

野馬生物（MBIO）的下一個分析師評級何時公佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mustang Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mustang Bio was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Mustang Bio的高管和客戶交談以及聽取業績電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Mustang Bio的最後一次評級是在2023年8月15日提交的，因此您應該預計下一個評級將在2024年8月15日左右公佈。

Is the Analyst Rating Mustang Bio (MBIO) correct?

分析師對 Mustang Bio (MBIO) 的評級正確嗎？

While ratings are subjective and will change, the latest Mustang Bio (MBIO) rating was a reiterated with a price target of $0.00 to $25.00. The current price Mustang Bio (MBIO) is trading at is $4.03, which is within the analyst's predicted range.

雖然評級是主觀的，會發生變化，但最新的Mustang Bio（MBIO）評級得到了重申，目標股價爲0.00美元至25.00美元。Mustang Bio（MBIO）目前的交易價格爲4.03美元，在分析師的預測區間內。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論